Henry Ford Health System:企業の戦略的SWOT分析

◆英語タイトル:Henry Ford Health System - Strategic SWOT Analysis Review
◆商品コード:GDPH24681SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Ford Health System – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Henry Ford Health System (HFHS) is a non-profit healthcare services entity, which provides acute, primary, tertiary, quaternary and preventive care services. The organization offers its services in the areas of cancer, dermatology, heart and vascular, lab services, neurology and neurosurgery, orthopaedics, primary care, radiology and imaging, urgent care, weight management and women’s health. HFHS operates through network of hospitals, medical centers and pharmacies. Its major hospitals comprise of Henry Ford Hospital; Henry Ford Macomb – Mt Clemens; Henry Ford Wyandotte Hospital; Henry Ford Allegiance Health; Henry Ford West Bloomfield Hospital; and Henry Ford Kingswood Hospital. The organization also offers community care services. HFHS is headquartered in Detroit, Michigan, the US.

Henry Ford Health System Key Recent Developments

Dec 10,2020: Henry Ford Health, Acadia Healthcare to build new facility in Michigan, US
Dec 07,2020: Henry Ford Health System receives $16 million gift to benefit Henry Ford Pancreatic Cancer Center
Aug 14,2020: Global Brand Leader to head Henry Ford Health System’s brand strategy and customer experience transformation
Aug 13,2020: HAP introduces innovative health plan for Michigan businesses in collaboration with Henry Ford Health System
Jun 30,2020: CarePort Health Platform shared by hospitals and post-acute care partners to ensure safe COVID-19 patient transitions

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Ford Health System – Key Facts
Henry Ford Health System – Key Employees
Henry Ford Health System – Key Employee Biographies
Henry Ford Health System – Major Products and Services
Henry Ford Health System – History
Henry Ford Health System – Company Statement
Henry Ford Health System – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Ford Health System – Business Description
Henry Ford Health System – SWOT Analysis
SWOT Analysis – Overview
Henry Ford Health System – Strengths
Henry Ford Health System – Weaknesses
Henry Ford Health System – Opportunities
Henry Ford Health System – Threats
Henry Ford Health System – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Henry Ford Health System, Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 10, 2020: Henry Ford Health, Acadia Healthcare to build new facility in Michigan, US
Dec 07, 2020: Henry Ford Health System receives $16 million gift to benefit Henry Ford Pancreatic Cancer Center
Aug 14, 2020: Global Brand Leader to head Henry Ford Health System’s brand strategy and customer experience transformation
Aug 13, 2020: HAP introduces innovative health plan for Michigan businesses in collaboration with Henry Ford Health System
Jun 30, 2020: CarePort Health Platform shared by hospitals and post-acute care partners to ensure safe COVID-19 patient transitions
Jun 04, 2020: Henry Ford Health System receives $266,000 grant from BET COVID-19 relief event through United Way for Southeastern Michigan
May 28, 2020: Henry Ford Health System welcomes new Senior Vice President and Chief Strategy Officer
Apr 28, 2020: Advaita Bioinformatics and Henry Ford Health System Discover that a Well-Known Drug Helps Prevent Worst COVID-19 Outcomes
Apr 13, 2020: Alternate care facility for Covid-19 patients opens in Michigan, US
Apr 02, 2020: Henry Ford Health System to lead national study to determine drug’s effectiveness in preventing COVID-19
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Ford Health System, Key Facts
Henry Ford Health System, Key Employees
Henry Ford Health System, Key Employee Biographies
Henry Ford Health System, Major Products and Services
Henry Ford Health System, History
Henry Ford Health System, Other Locations
Henry Ford Health System, Subsidiaries
Henry Ford Health System, Key Competitors
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Henry Ford Health System, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Henry Ford Health System, Recent Deals Summary

★海外企業調査レポート[Henry Ford Health System:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MyCartis NV-医療機器分野:企業M&A・提携分析
    Summary MyCartis NV (MyCartis), formerly Pronota NV is a biomarker analysis solution provider. The company develops multiplexed biomarker solutions through evalution and bio assays technology. It uses technologies such as barcoded microparticles, microfluidic assay cartridges and evalution instrumen …
  • Hexicon AB:電力:M&Aディール及び事業提携情報
    Summary Hexicon AB (Hexicon) is a design and engineering company that manufactures and develops floating multi-platforms for offshore wind energy production. The company offers utilities to the developers for managing and utilizing the power of offshore wind and Hexicon platforms, and provides tank …
  • IES Holdings, Inc.:企業の戦略・SWOT・財務情報
    IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary IES Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Etam Developpement SCA:企業の戦略・SWOT・財務情報
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Konecranes Plc
    Konecranes Plc - Strategy, SWOT and Corporate Finance Report Summary Konecranes Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ZoomMed Inc (ZMD):医療機器:M&Aディール及び事業提携情報
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Onxeo SA:企業のM&A・事業提携・投資動向
    Onxeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Onxeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Capsugel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Fugro NV (FUR):企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lisi Aerospace SAS:企業の戦略・SWOT・財務分析
    Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report Summary Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Meridian Bioscience Inc (VIVO):企業の財務・戦略的SWOT分析
    Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Appili Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral suspension antibiotic liquid reformulation …
  • Snap-on Incorporated (SNA):企業の財務・戦略的SWOT分析
    Snap-on Incorporated (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Essar Power Ltd:企業の戦略的SWOT分析
    Essar Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • H. Lundbeck AS (LUN):製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. Its products are indicate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆